Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossMedicare Advantage · Billing Codes · Medical Policy · Allergy & Immunology, Hematology, Oncology +6 moreMedium impact

MA08.009y, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)

Act
by Mar 31, 2026
Effective date
Apr 1, 2026
Identified
Jun 19, 2026

Summary

Independence Blue Cross Medicare Advantage policy MA08.009z (effective 04/01/2026) removes HCPCS code J1599 (nonlyophilized immune globulin, 500 mg) and adds J1553 (yimmugo immune globulin, 100 mg) for IVIG/SCIG coverage. Billing teams must update systems to reject claims using the discontinued J1599 code and ensure new J1553 claims are processed appropriately.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

by Mar 31, 2026 · 3 steps
01Billing team must update billing system to (1) REMOVE HCPCS code J1599 from the list of covered codes under policy MA08.009z, (2) ADD HCPCS code J1553 as a newly covered code, and (3) configure system to deny or reject any claims submitted with J1599 on or after April 1, 2026.
02Update encounter forms and billing software to route J1553 claims through appropriate coverage verification.
03Communicate change to providers and clinical staff.
If missed: Failure to implement by effective date will result in claim denials for J1599 and processing delays for J1553 claims.

Codes mentioned

J1599J1553J1555J1558J1559J1561J1569J1575

Original notice

MA08.009y, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related changes

See all Independence Blue Cross changes →
MA08.009w, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)MediumEffective Jan 1, 2025 · Medical Policy08.00.13am, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)HighEffective Jan 1, 2026 · Medical PolicyMA08.009z, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)LowEffective Jul 1, 2026 · Medical Policy08.00.13ao, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)LowEffective Jul 1, 2026 · Medical PolicyBrowse every Independence Blue Cross change in the policy list

Related policy hubs

Independence Blue Cross policiesAllergy & ImmunologyHematologyOncologyRheumatologyNeurologyDermatologyTransplant SurgeryPediatricsInfectious DiseaseCode J1599Code J1553Code J1555Code J1558Code J1559Code J1561Code J1569Code J1575

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account